FXS5626 tablet

DRUG2 trials

Sponsors

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

Conditions

Active Non-anterior, Non-infectious UveitisEvaluation of QTc Interval

Phase 1

QT Interval Effects Study of Oral FXS5626 Tablets

Not yet recruitingNCT07695779

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Evaluation of QTc Interval

Start: 2026-08-05End: 2026-09-25Target: 28Updated: 2026-07-10

Phase 2

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU

RecruitingNCT07552012

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Active Non-anterior, Non-infectious Uveitis

Start: 2026-01-29End: 2027-12-31Target: 40Updated: 2026-04-27